A Dose-escalation and Safety & Efficacy Study of AXO-AAV-GM2 in Tay-Sachs or Sandhoff Disease
Clinical trial NCT04669535 · TERMINATED
Trial details
- NCT number
- NCT04669535
- Sponsor
- Terence Flotte
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-15
- Primary completion
- 2024-05-23
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.